Skip to main content
. 2021 Aug 2;21:368. doi: 10.1186/s12872-021-02186-0

Table 1.

Demographics and baseline characteristics of the study cohort

Unfavorable outcome
(n = 47)
Favorable outcome
(n = 47)
P value
Female 53.2% 46.8% 0.54
Age 82.0 ± 7.8 80.7 ± 9.6 0.49
White race 94% 100% 0.08
Diabetes 45% 30% 0.14
Systemic steroids 11% 8.5% 0.73
Other immunosuppression 6.4% 4.2% 0.65
BMIa 28.8 ± 8.1 28.1 ± 6.9 0.64
Smoking status 0.71
 Current 2.1% 4.3%
 Former 57.4% 60.0%
 Never 38.3% 36.2%
Reason for TAVR 0.16
 Inoperable/extreme risk 12.7% 2.1%
 High risk 61.7% 72.3%
 Intermediate risk 19.1% 23.4%
 Other 6.4% 2.1%
Gait speed
 Unable to walk 2% 17% 0.01
 5 M walk speed (s) 9.4 ± 0.67 8.3 ± 4.4 0.69
Grip strength
 Men (kg) 25.6 ± 6.6 28.3 ± 10.7 0.31
 Women (kg) 14.3 ± 6.4 14.7 ± 4.7 0.79
Baseline KCCQb score 45.2 ± 18.5 49.8 ± 20.6 0.54
STSc score 5.4 ± 3.4 4.8 ± 3.2 0.34
Columbia Frailty score 5.0 ± 2.6 5.1 ± 3.2 0.85

Results presented as percent or mean ± SD

aBMI = Body mass index

bKCCQ = Kansas City Cardiomyopathy Questionnaire

cSTS = Society for Thoracic Surgeons